Dataset Information


ATF4 contributes to autophagy and survival in sunitinib treated brain tumor initiating cells (BTICs).

ABSTRACT: Receptor tyrosine kinase (RTK) pathways are known to play an important role in tumor cell proliferation of glioblastoma (GBM). Cellular determinants of RTK-inhibitor sensitivity are important to optimize and tailor treatment strategies. The stress response gene activating transcription factor 4 (ATF4) is involved in homeostasis and cellular protection. However, little is known about its function in GBM. We found that the ATF4/p-eIF2? pathway is activated in response to Sunitinib in primary tumor initiating progenitor cell cultures (BTICs). Furthermore, lysosome entrapment of RTK-inhibitors (RTK-Is) leads to accumulation of autophagosomes. In case of Sunitinib treated cells, autophagy is additionally increased by ATF4 mediated upregulation of autophagy genes. Inhibition of ATF4 by small interfering RNA (siRNA) reduced autophagy and cell proliferation after Sunitinib treatment in a subset of BTIC cultures. Overall, this study suggests a pro-survival role of the ATF4/p-eIF2? pathway in a cell type and treatment specific manner.


PROVIDER: S-EPMC6349458 | BioStudies | 2019-01-01

REPOSITORIES: biostudies

Similar Datasets

1000-01-01 | S-EPMC4767234 | BioStudies
2013-01-01 | S-EPMC3984242 | BioStudies
1000-01-01 | S-EPMC3763548 | BioStudies
2017-01-01 | S-EPMC5544292 | BioStudies
1000-01-01 | S-EPMC4047911 | BioStudies
1000-01-01 | S-EPMC5492387 | BioStudies
1000-01-01 | S-EPMC3688014 | BioStudies
1000-01-01 | S-EPMC5352398 | BioStudies
2015-01-01 | S-EPMC4618251 | BioStudies
1000-01-01 | S-EPMC5143407 | BioStudies